Clinical trialNCT00081783UnknownPhase 2Interventional

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

SponsorXcyte TherapiesEnrollment40Non-Hodgkin's Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark W. Frohlich, MD
Xcyte Therapies
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

California Cancer Care
Greenbrae, California, United States
Jennifer B. Lucas, MD
Recruiting
University of Southern California
Los Angeles, California, United States
Ann Mohrbacher, MD
Not, yet, recruiting
Sharp Memorial Hospital
San Diego, California, United States
Charles Redfern, MD
Recruiting
University of California, San Diego
San Diego, California, United States
Januario E. Castro, MD
Recruiting
University of California, San Francisco
San Francisco, California, United States
Lawrence D. Kaplan, MD
Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Peter McSweeney, MD
Recruiting
Atlanta Cancer Care
Roswell, Georgia, United States
Ronald G. Steis, MD
Recruiting
Johns Hopkins University
Baltimore, Maryland, United States
Ian W. Flinn, MD, PhD
Recruiting
Center for Cancer & Blood Disorders
Bethesda, Maryland, United States
Ralph V. Boccia, MD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Arnold Freedman, MD
Recruiting
Washington University
St Louis, Missouri, United States
Nancy L. Bartlett, MD
Recruiting
Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Roger K. Strair, MD, PhD
Recruiting
Ohio State University
Columbus, Ohio, United States
Thomas Lin, MD
Recruiting
Oregon Health Sciences University
Portland, Oregon, United States
Brandon Hayes-Lattin, MD
Recruiting
Cancer Centers of the Carolinas
Greenville, South Carolina, United States
Joe J. Stephenson, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Peter W. McLaughlin, MD
Recruiting
Swedish Cancer Institute
Seattle, Washington, United States
Michael S. Milder, MD
Recruiting
Virginia Mason
Seattle, Washington, United States
David M. Aboulafia, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2004
Primary completion: —
Completion: —
Last update posted: 24 Jun 2005
Registered enrollment: 40
Registry id: NCT00081783

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.